Literature DB >> 15261874

Movement disorders and AIDS: a review.

Winona Tse1, Maria G Cersosimo, Jean-Michel Gracies, Susan Morgello, C Warren Olanow, William Koller.   

Abstract

Movement disorders are a potential neurologic complication of acquired immune deficiency syndrome (AIDS), and may sometimes represent the initial manifestation of HIV infection. Dopaminergic dysfunction and the predilection of HIV infection to affect subcortical structures are thought to underlie the development of movement disorders such as parkinsonism in AIDS patients. In this review, we will discuss the clinical presentations, etiology and treatment of the various AIDS-related hypokinetic and hyperkinetic movement disorders, such as parkinsonism, chorea, myoclonus and dystonia. This review will also summarize current concepts regarding the pathophysiology of parkinsonism in HIV infection.

Entities:  

Mesh：

Year:  2004        PMID： 15261874     DOI： 10.1016/j.parkreldis.2004.03.001

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN： 1353-8020            Impact factor:   4.891


  33 in total

1.  Reversible progressive supranuclear palsy-like phenotype as an initial manifestation of HIV infection.

Authors:  Wooyoung Jang; Joong-Seok Kim; Jin Young Ahn; Hee-Tae Kim
Journal:  Neurol Sci       Date:  2011-12-09       Impact factor: 3.307

Review 2.  Juvenile parkinsonism: epidemiology, diagnosis and treatment.

Authors:  Teri R Thomsen; Robert L Rodnitzky
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

3.  Opsoclonus-myoclonus-ataxia syndrome and HIV seroconversion.

Authors:  Ana Ayarza; Virginia Parisi; Javier Altclas; Daniela Visconti; Gabriel Persi; Carlos A Rugilo; Emilia M Gatto
Journal:  J Neurol       Date:  2009-02-28       Impact factor: 4.849

4.  Reversible movement disorders due to toxoplasmosis as initial manifestation of HIV-AIDS, with sequential MR and video imaging.

Authors:  Antonio Jose Reyes; Kanterpersad Ramcharan; Samuel Aboh; Nathaniel Duke
Journal:  BMJ Case Rep       Date:  2016-06-16

5.  Selective Vulnerability of Striatal D2 versus D1 Dopamine Receptor-Expressing Medium Spiny Neurons in HIV-1 Tat Transgenic Male Mice.

Authors:  Christina J Schier; William D Marks; Jason J Paris; Aaron J Barbour; Virginia D McLane; William F Maragos; A Rory McQuiston; Pamela E Knapp; Kurt F Hauser
Journal:  J Neurosci       Date:  2017-05-04       Impact factor: 6.167

Review 6.  Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention--A Comparison with Parkinson's Disease.

Authors:  S DeVaughn; E M Müller-Oehring; B Markey; H M Brontë-Stewart; T Schulte
Journal:  Neuropsychol Rev       Date:  2015-11-17       Impact factor: 7.444

7.  Tic Disorder: An Unusual Presentation of Neurotoxoplasmosis in a Patient with AIDS.

Authors:  Camila Catherine Henriques Aquino; André Carvalho Felício; Clecio Godeiro-Junior; Denizart Santos-Neto; José Luiz Pedroso; Acary Souza Bulle Oliveira; Sônia Maria Azevedo Silva; Vanderci Borges; Henrique Ballalai Ferraz
Journal:  Case Rep Neurol       Date:  2010-11-15

Review 8.  Viral parkinsonism.

Authors:  Haeman Jang; David A Boltz; Robert G Webster; Richard Jay Smeyne
Journal:  Biochim Biophys Acta       Date:  2008-08-12

Review 9.  Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS.

Authors:  Mark J Ferris; Charles F Mactutus; Rosemarie M Booze
Journal:  Neurosci Biobehav Rev       Date:  2008-03-18       Impact factor: 8.989

Review 10.  Cognitive neuropsychology of HIV-associated neurocognitive disorders.

Authors:  Steven Paul Woods; David J Moore; Erica Weber; Igor Grant
Journal:  Neuropsychol Rev       Date:  2009-05-22       Impact factor: 7.444
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.